Slower Growth In Diagnostics Stocks Except For NexGen Sequencing And Molecular

New technologies in diagnostics and tools are driving growth: NexGen sequencing, molecular and “point-of-care” testing platforms and veterinary testing. The sector is a laggard due to slowing sales and earnings growth.